On the other hand, based on the fact that IL-6 is essential in anemia related to chronic diseases, it is possible that anti-IL6R therapy could improve anemia markers more effectively than other biologics (Suzuki et al., 2017[37]). Here, IL6R is linked to anemia (phenotype).